Are You Published?

Ellie JC Goldstein, MD, director, RM Alden Research Laboratory

Johnson S, DM Citron, DN Gerding, MH Wilcox, EJ C Goldstein, SP Sambol, EL Best, K Eves, E Jensen, MB Dorr, Efficacy of Bezlotoxumab in Trial Participants Infected with Clostridioides difficile Strain BI Associated with Poor Outcomes, Clinical Infectious Diseases, 73; e2616–e2624, 2021

Santosh Kesari, MD, PhD, Neuro-oncology, Pacific Neuroscience Institute

A phase I study of the WT2725 dosing emulsion in patients with advanced malignancies.

Fu S, Piccioni DE, Liu H, Lukas RV, Kesari S, Aregawi D, Hong DS, Yamaguchi K, Whicher K, Zhang Y, Chen YL, Poola N, Eddy J, Blum D.Sci Rep. 2021 Nov 16;11(1):22355. doi: 10.1038/s41598-021-01707-3.PMID: 34785698 Free PMC article.

Marizomib alone or in combination with bevacizumab in patients with recurrent glioblastoma: Phase I/II clinical trial data.

Bota DA, Mason W, Kesari S, Magge R, Winograd B, Elias I, Reich SD, Levin N, Trikha M, Desjardins A.Neurooncol Adv. 2021 Oct 2;3(1):vdab142. doi: 10.1093/noajnl/vdab142. eCollection 2021 Jan-Dec.PMID: 34729484 Free PMC article.

Measurements of Functional Network Connectivity Using Resting State Arterial Spin Labeling During Neurosurgery.

Lindner T, Ahmeti H, Helle M, Jansen O, Fiehler J, Dührsen L, Synowitz M, Kesari S, Ulmer S.World Neurosurg. 2021 Oct 18;157:152-158. doi: 10.1016/j.wneu.2021.10.107. Online ahead of print.PMID: 34673240

Plexin-B2 orchestrates collective stem cell dynamics via actomyosin contractility, cytoskeletal tension and adhesion.

Junqueira Alves C, Dariolli R, Haydak J, Kang S, Hannah T, Wiener RJ, DeFronzo S, Tejero R, Gusella GL, Ramakrishnan A, Alves Dias R, Wojcinski A, Kesari S, Shen L, Sobie EA, Rodrigues Furtado de Mendonça JP, Azeloglu EU, Zou H, Friedel RH.Nat Commun. 2021 Oct 14;12(1):6019. doi: 10.1038/s41467-021-26296-7.PMID: 34650052 Free PMC article.

DNA Damage Response in Glioblastoma: Mechanism for Treatment Resistance and Emerging Therapeutic Strategies.

Bonm A, Kesari S.Cancer J. 2021 Sep-Oct 01;27(5):379-385. doi: 10.1097/PPO.0000000000000540.PMID: 34570452 Review.

Treatment of Dementia With Bosutinib: An Open-Label Study of a Tyrosine Kinase Inhibitor.

Mahdavi KD, Jordan SE, Barrows HR, Pravdic M, Habelhah B, Evans NE, Blades RB, Iovine JJ, Becerra SA, Steiner RA, Chang M, Kesari S, Bystritsky A, O'Connor E, Gross H, Pereles FS, Whitney M, Kuhn T.Neurol Clin Pract. 2021 Jun;11(3):e294-e302. doi: 10.1212/CPJ.0000000000000918.PMID: 34484904

Daniel Kelly, MD, neurosurgeon, Pacific Neuroscience Institute

Diagnostic Pitfalls in Cushing Disease: Surgical Remission Rates, Test Thresholds, and Lessons Learned in 105 Patients


If you would like to share your published articles, please email us the paper and/or link to:

Previous Article
Did You Know ...
Did You Know ...

Providence Southern California has a full range of chemical dependency and mental health services?

Next Article
Give Us Your Feedback
Give Us Your Feedback

Tell us what you think about Clinical Connections.